Aoxing Pharmaceutical Company

AOXG

Drug Manufacturers - Specialty & Generic · Healthcare

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Aoxing Pharmaceutical Company is a small drug company focused on treatments for opioid addiction and pain management. Its main product is a buprenorphine-based medication, which helps people reduce dependence on opioids. The company targets patients and healthcare providers in China, where opioid addiction treatment has historically been underserved.

The company earns revenue by selling its pharmaceutical products directly into the Chinese healthcare market. It is a very small company with a market cap near zero, meaning it has limited financial resources compared to larger drug makers. The high gross margin suggests the core product carries decent pricing power, but the deeply negative operating margin means the company is spending far more than it earns, which is a serious financial risk. The main challenge ahead is achieving enough sales volume to cover its operating costs before it runs out of cash.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

+100.0% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

39.4%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~7 years

$23,829 cash & investments

$23,829 cash & investments at current burn rate

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

N/A

Data not available

Operating Margin

N/A

Data not available

ROCE

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

—

Data not available

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

-622.1%

Burning cash (-622.1%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

Data not available

Interest Cover

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial